Interpace Diagnostics Group's market cap is currently ―. The company's EPS TTM is $0.184; its P/E ratio is 7.94; Interpace Diagnostics Group is scheduled to report earnings on May 13, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	$ 9.08M	$ 11.03M	$ 9.83M	$ 3.92M	$ 8.19M
Gross Profit	$ 4.95M	$ 6.83M	$ 5.98M	$ 5.00M	$ 4.73M
EBIT	$ -524.00K	$ 399.00K	$ 434.00K	$ 1.51M	$ -997.00K
EBITDA	$ -270.00K	$ 771.00K	$ 804.00K	$ 1.39M	$ -362.00K
Net Income Common Stockholders	$ -614.00K	$ 175.00K	$ 18.66M	$ -1.56M	$ -14.21M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 5.03M	$ 5.08M	$ 5.60M	$ 4.83M	$ 6.31M
Total Assets	$ 14.25M	$ 15.94M	$ 15.88M	$ 15.98M	$ 15.29M
Total Debt	$ 13.12M	$ 14.45M	$ 15.08M	$ 15.51M	$ 13.34M
Net Debt	$ 8.09M	$ 9.37M	$ 9.48M	$ 10.69M	$ 7.03M
Total Liabilities	$ 30.39M	$ 78.15M	$ 31.88M	$ 32.52M	$ 76.89M
Stockholders Equity	$ -62.68M	$ -62.21M	$ -62.54M	$ -63.07M	$ -61.59M
Cash Flow	-
Free Cash Flow	$ 953.00K	$ 300.00K	$ 1.07M	$ -472.00K	$ -3.28M
Operating Cash Flow	$ 1.10M	$ 411.00K	$ 1.13M	$ -276.00K	$ -3.24M
Investing Cash Flow	$ 348.00K	$ -228.00K	$ -65.00K	$ -1.10M	$ 7.39M
Financing Cash Flow	$ -1.50M	$ -700.00K	$ -300.00K	$ -106.00K	$ 47.00K

Currency in USD

Interpace Diagnostics Group Earnings and Revenue History

Income Statement >

Interpace Diagnostics Group Debt to Assets

Balance Sheet >

Interpace Diagnostics Group Cash Flow

Cash Flow >

Interpace Diagnostics Group Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing